Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

June 30, 2018

Conditions
Non Small Cell Lung Cancer
Interventions
RADIATION

Intensity Modulated Radiotherapy treatment

Intensity Modulated Radiotherapy treatment

Trial Locations (7)

Unknown

Belfast Health & Social Care NHS Trust - Northern Ireland Cancer Centre, Belfast

Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital, Cambridge

Beatson West of Scotland Cancer Centre, Glasgow

Leeds Teaching Hospitals NHS Trust - St James's University Hospital, Leeds

The Christie NHS Foundation Trust, Manchester

Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital, Sheffield

The Royal Marsden NHS Foundation Trust, Surrey

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

British Lung Foundation

OTHER

collaborator

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

collaborator

Belfast Health and Social Care Trust

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Royal Marsden NHS Foundation Trust

OTHER

collaborator

East and North Hertfordshire NHS Trust

OTHER_GOV

lead

Prof Corinne Faivre-Finn

OTHER

NCT01836692 - Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study | Biotech Hunter | Biotech Hunter